James H. Day
Department of Medicine
Queen's University and Division of Allergy and Immunology
Kingston General Hospital
Kingston
Canada
Name/email consistency: high
- Onset of action of loratadine/montelukast in seasonal allergic rhinitis subjects exposed to ragweed pollen in the Environmental Exposure Unit. Day, J.H., Briscoe, M.P., Ratz, J.D., Ellis, A.K., Yao, R., Danzig, M. Allergy. Asthma. Proc (2009)
- Efficacy of loratadine-montelukast on nasal congestion in patients with seasonal allergic rhinitis in an environmental exposure unit. Day, J.H., Briscoe, M.P., Ratz, J.D., Danzig, M., Yao, R. Ann. Allergy Asthma Immunol. (2009)
- Efficacy of levocetirizine compared with montelukast in subjects with ragweed-induced seasonal allergic rhinitis in the Environmental Exposure Unit. Day, J.H., Briscoe, M.P., Ratz, J.D. Allergy. Asthma. Proc (2008)
- Experimental models for the evaluation of treatment of allergic rhinitis. Day, J.H., Ellis, A.K., Rafeiro, E., Ratz, J.D., Briscoe, M.P. Ann. Allergy Asthma Immunol. (2006)
- Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU). Day, J.H., Briscoe, M.P., Rafeiro, E., Ratz, J.D. Int. J. Clin. Pract. (2004)
- Levocetirizine: a new selective H1 receptor antagonist for use in allergic disorders. Day, J.H., Ellis, A.K., Rafeiro, E. Drugs. Today (2004)
- Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system. Day, J.H., Briscoe, M., Rafeiro, E., Chapman, D., Kramer, B. Ann. Allergy Asthma Immunol. (2001)
